Data / Form D filings / Immunaeon Inc.
Immunaeon Inc.: Form D filing
Immunaeon Inc., a biotechnology company in Buffalo, NY, filed a Form D with the SEC in 2023. The latest, on April 4, 2023, reports $250,000 sold of an offering with no set size to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 701 ELLICOTT STREET, Buffalo, NY, 14203
- Phone
- (716) 336-6543
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- New York
- Year incorporated
- 2018
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1971360
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 4, 2023 | New notice | Indefinite | $250,000 | 1 | Feb 23, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Adam Utley | Executive Officer | |
| Daniel Rera | Executive Officer | |
| Joseph Dinardo | Executive Officer |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Apr 3, 2023 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Immunaeon Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.